TIMELESS deficiency sensitizes thyroid cancer to cisplatin treatment via the DNA damage repair pathway
Abstract DNA damage repair (DDR) pathway was activated in thyroid cancer under cisplatin treatment. TIMELESS, a circadian rhythm gene, was…
Abstract DNA damage repair (DDR) pathway was activated in thyroid cancer under cisplatin treatment. TIMELESS, a circadian rhythm gene, was…
Abstract Background/Objectives: Cannabidiol (CBD) is known for its anti-cancer properties in preclinical models and is increasingly used alongside conventional chemotherapy…
Abstract Background: Cisplatin is an anti-cancer drug used to treat a plethora of solid tumors. However, it is associated with…
Abstract Introduction: Cannabinoids are reported to suppress the growth of ovarian cancer cells, but it is unclear whether structural modifications…
Abstract Chemotherapy is a therapy of choice for many cancers. However, it is often inefficient for long-term patient survival and…
Abstract Cisplatin and other platinum-derived chemotherapy drugs have been used for the treatment of cancer for a long time and…
Abstract Cannabigerol (CBG), derived from the cannabis plant, acts as an acute analgesic in a model of cisplatin-induced peripheral neuropathy…
Abstract Platinum-derived chemotherapy medications are often combined with other conventional therapies for treating different tumors, including colorectal cancer. However, the…
Abstract Introduction: With the legalization of cannabis in multiple jurisdictions throughout the world, a larger proportion of the population consumes…
Abstract Background: Prostate cancer is the second most frequently occurring carcinoma in males worldwide and one of the leading causes…